Edition:
United Kingdom

Orthofix International NV (OFIX.OQ)

OFIX.OQ on NASDAQ Stock Exchange Global Select Market

60.75USD
20 Jun 2018
Change (% chg)

$0.32 (+0.53%)
Prev Close
$60.43
Open
$60.34
Day's High
$60.77
Day's Low
$59.46
Volume
94,505
Avg. Vol
56,004
52-wk High
$61.79
52-wk Low
$42.72

Chart for

About

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include... (more)

Overall

Beta: 0.11
Market Cap(Mil.): $920.90
Shares Outstanding(Mil.): 18.17
Dividend: --
Yield (%): --

Financials

  OFIX.OQ Industry Sector
P/E (TTM): 124.16 32.19 32.74
EPS (TTM): 0.41 -- --
ROI: 2.61 13.89 14.38
ROE: 2.88 16.72 16.08

BRIEF-Orthofix International NV Reports Q1 EPS Of $0.27 From Continuing Operations

* Q1 ADJUSTED EARNINGS PER SHARE $0.39 FROM CONTINUING OPERATIONS

30 Apr 2018

BRIEF-Orthofix Receives FDA 510(K) Clearance Of G-Beam Fusion Beaming System

* ORTHOFIX RECEIVES FDA 510(K) CLEARANCE OF G-BEAM FUSION BEAMING SYSTEM

22 Mar 2018

BRIEF-Orthofix Announces Agreement To Acquire Spinal Kinetics

* ORTHOFIX INTERNATIONAL NV - TERMS OF DEAL INCLUDE $45 MILLION IN CASH CLOSING CONSIDERATION PLUS UP TO $60 MILLION IN CONTINGENT MILESTONE PAYMENTS

15 Mar 2018

BRIEF-Orthofix Announces Appointment Of John Sicard To Board Of Directors

* ORTHOFIX ANNOUNCES APPOINTMENT OF JOHN SICARD TO BOARD OF DIRECTORS

13 Mar 2018

BRIEF-Orthofix Secures FDA And CE Mark Approvals For New Physiostim Bone Growth Stimulators

* ORTHOFIX SECURES FDA AND CE MARK APPROVALS FOR NEW PHYSIOSTIM BONE GROWTH STIMULATORS Source text for Eikon: Further company coverage:

07 Mar 2018

BRIEF-Orthofix International Reports Q4 EPS Of $0.08 From Continuing Operations

* ORTHOFIX INTERNATIONAL REPORTS FOURTH QUARTER AND FISCAL 2017 FINANCIAL RESULTS

26 Feb 2018

BRIEF-Orthofix Announces 510(K) Clearance For FORZA XP Expandable Spacer System

* ORTHOFIX ANNOUNCES 510(K) CLEARANCE AND U.S. LIMITED MARKET LAUNCH OF FORZA XP EXPANDABLE SPACER SYSTEM

06 Feb 2018

BRIEF-Orthofix Announces Preliminary 2017 Fourth Quarter

* SAYS EXPECTS TO RECOGNIZE A ONE-TIME, NON-CASH TAX CHARGE OF $8 MILLION - $12 MILLION IN Q4 OF 2017

09 Jan 2018

Competitors

Earnings vs. Estimates